Centre for Applied Health Economics, School of Medicine, and Dentistry, Griffith University, 170 Kessels Road, Nathan, QLD, 4111, Australia.
Menzies Health Institute, Griffith University, Queensland, Australia.
Arch Orthop Trauma Surg. 2023 Sep;143(9):5787-5792. doi: 10.1007/s00402-023-04891-1. Epub 2023 Apr 27.
Studies have shown that debridement, antibiotics, and implant retention (DAIR) is an effective procedure for acute infection of total knee arthroplasty (TKA). This study aimed to explore DAIR and one-stage revision for homogenous cohorts with acute postoperative and acute hematogenous infection of TKA, without compelling indications to perform a staged revision.
This study was an exploratory analysis that used retrospective data from Queensland Health, Australia, for DAIR and one-stage revision of TKA between June 2010 and May 2017 (3-year average follow-up). The re-revision burden, mortality rate, and the cost of the interventions were explored. Costs were expressed in 2020 Australian dollars.
There were 15 (DAIR) and 142 (one-stage) patients with homogenous characteristics in the sample. The re-revision burden for DAIR was 20%, while for one-stage revision it was 12.68%. Two deaths were associated with a one-stage revision and no death was associated with DAIR. The total cost since the index revision of DAIR, $162,939, was higher than for one-stage revision $130,924 (p value = 0.501), due to higher re-revision burden.
This study would suggest the use of one-stage revision over DAIR for acute postoperative and acute hematogenous infection of TKA. It suggests that there could be other potential criteria which have not been ascertained that need to be considered for optimal DAIR selection. The study indicates the need for more research and, of note, high-quality randomized controlled trials to provide a well-defined treatment protocol with high level of evidence to guide patient selection for DAIR.
研究表明,清创、抗生素和植入物保留(DAIR)是治疗全膝关节置换术(TKA)急性感染的有效方法。本研究旨在探讨 DAIR 和一期翻修在 TKA 急性术后和急性血源性感染的同质队列中的应用,这些患者没有强烈的分期翻修指征。
这是一项探索性分析,使用了来自澳大利亚昆士兰州卫生署 2010 年 6 月至 2017 年 5 月(平均 3 年随访)期间的 TKA 的 DAIR 和一期翻修的回顾性数据。研究了再次翻修负担、死亡率和干预成本。成本以 2020 年澳元表示。
样本中共有 15 例(DAIR)和 142 例(一期翻修)具有同质特征的患者。DAIR 的再次翻修负担为 20%,而一期翻修为 12.68%。有 2 例死亡与一期翻修有关,而与 DAIR 无关。DAIR 的指数翻修后的总成本为 162939 美元,高于一期翻修的 130924 美元(p 值=0.501),这是由于再次翻修负担较高。
本研究表明,对于 TKA 的急性术后和急性血源性感染,应优先采用一期翻修而非 DAIR。这表明可能存在其他尚未确定的潜在标准,需要考虑以确定最佳 DAIR 选择。该研究表明需要进行更多的研究,特别是高质量的随机对照试验,以提供具有高度证据的明确治疗方案,从而指导患者选择 DAIR。